You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2

Test Information

The Need

Repeat molecular testing for multiple pathogens is time-consuming. Actionable, syndromic real-time PCR diagnostic tests are needed to allow healthcare providers to efficiently treat their patients.

Rapid and easy-to-use multiplexing technology enables the detection of multiple mutations across several genes, in a single sample.

The Impact

A new era of high-level multiplexing real-time PCR instruments will revolutionize molecular diagnostics with:

  • Independent monitoring of 10 or more signals in a single reaction tube
  • The power to detect a broader spectrum of pathogens and antimicrobial resistance
  • More clinically actionable results and faster access to treatment decisions

The Solution

GeneXpert 10-Color Systems Deliver:

  • Multiplexing technology for an expanding test menu
  • The same, simple workflow on a single, flexible platform, for both point-of-care* and hospital settings
  • A modular system capable of scaling to meet changing testing needs 

By using probes labeled with different fluorescent reporter dyes, numerous targets can be detected simultaneously in a single reaction tube. Since four more fluorescent channels are now available, the number of possible targets increases, allowing for more complex assay designs. Each target can be independently monitored by the innovative excitation-emission system in the Cepheid GeneXpert 10-Color System.

With this increased testing power we can detect a wide range of bacteria and viruses, as well as fungi with one test. Additionally, this technology also makes it possible to identify multiple antimicrobial resistance markers from one sample.

For example, with the first Cepheid 10-Color test, Xpert® MTB/XDR#, the 10-Color Module significantly increases the assay multiplexing capacity, which in turn expands the number of antimicrobial resistance genes that can be detected. 

The new 10-Color assay targets as many as eight genes for detection of M. tuberculosis and resistance to as many as six drugs: isoniazid, fluoroquinolones, amikacin, kanamycin, capreomycin and ethionamide.

Multiplexing Test Pipeline^

US-IVD 2022^ CE-IVD 2022^
Carba-R NxG Carba-R NxG
GI Panel GI Panel
Respiratory Panel Respiratory Panel
Tropical Fever Panel Tropical Fever Panel
  MTB/RIF/INH

 

Learn About Cepheid GeneXpert® Systems

 

GeneXpert® Infinity Systems

“Load and go” technology delivers total automation for up to 2,000 tests a day.

Explore the potential

GeneXpert® Systems

Available in 1, 2, 4 or 16-module configurations that all use the same cartridge technology.
 

Explore the potential
* Not all Cepheid tests have been cleared for point-of-care or Near Patient Testing settings.
Product in development. Not for use in diagnostic procedures. Not reviewed by any regulatory body. Products in development are subject to change and target menu is subject to revision.
# In Vitro Diagnostic Medical Device. May not be available in all countries. Not available in the United States.
Back to Top